軟部組織肉腫患者の臨床遺伝学的解析は、CDKN2A欠失が不良予後のバイオマーカーであることを明らかにします

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas2017 · 1,075 citations
2. 2Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 Genes and Their Prognostic Implications in Osteosarcoma and Ewing Sarcoma2000 · 178 citations
3. 3Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data1997 · 1,052 citations
4. 4Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data1997 · 692 citations
5. 5Clinical Trial Substantiates the Predictive Value of <b> <i>O-6-Methylguanine-DNA Methyltransferase</i> </b> Promoter Methylation in Glioblastoma Patients Treated with Temozolomide2004 · 791 citations